Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Blood
|
April 22, 2016
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis
Bernd Hartz, Rebecca Marsh, Kanchan Rao, et al.
Haematologica
|
February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia
Sandra Preuner, Christina Peters, Ulrike Pötschger, et al.
American Journal of Hematology
|
June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia
Sujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Blood
|
April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia
Johannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia
|
September 13, 2022
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial
Anna Eichinger, Ulrike Poetschger, Evgenia Glogova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
Tim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
Blood Advances
|
November 27, 2024
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
Krzysztof Kalwak, Laura M Moser, Ulrike Pötschger, et al.
The New England Journal of Medicine
|
April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
Franco Locatelli, Peter Lang, Donna Wall, et al.
Blood Advances
|
October 25, 2019
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets
Jessica I Hoell, Sebastian Ginzel, Michaela Kuhlen, et al.
The New England Journal of Medicine
|
April 25, 2024
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Haydar Frangoul, Franco Locatelli, Akshay Sharma, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Blood
|
April 22, 2016
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis
Bernd Hartz, Rebecca Marsh, Kanchan Rao, et al.
Haematologica
|
February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia
Sandra Preuner, Christina Peters, Ulrike Pötschger, et al.
American Journal of Hematology
|
June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia
Sujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Blood
|
April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia
Johannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia
|
September 13, 2022
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial
Anna Eichinger, Ulrike Poetschger, Evgenia Glogova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
Tim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
Blood Advances
|
November 27, 2024
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
Krzysztof Kalwak, Laura M Moser, Ulrike Pötschger, et al.
The New England Journal of Medicine
|
April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
Franco Locatelli, Peter Lang, Donna Wall, et al.
Blood Advances
|
October 25, 2019
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets
Jessica I Hoell, Sebastian Ginzel, Michaela Kuhlen, et al.
The New England Journal of Medicine
|
April 25, 2024
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Haydar Frangoul, Franco Locatelli, Akshay Sharma, et al.
Page
of 13